The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma – Survival analysis of 3892 patients
Jing‐Houng Wang(Kaohsiung Chang Gung Memorial Hospital), Sheng‐Nan Lu(Kaohsiung Chang Gung Memorial Hospital), Tai-Yi Chen(Kaohsiung Chang Gung Memorial Hospital), Tsung‐Hui Hu(National Sun Yat-sen University), Chuan–Mo Lee(Chang Gung University), Kwong‐Ming Kee(Kaohsiung Chang Gung Memorial Hospital), Chao‐Long Chen, Yu-Jie Huang(Chang Gung University), Chi‐Sin Changchien(Kaohsiung Chang Gung Memorial Hospital), Chih‐Yun Lin(Chang Gung University)
Cited by 195
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
|Gastroenterology|2008|547
Hepatogastroenterology
|Hepatogastroenterology|2012|536